A publication reviewing randomized controlled trials for vitiligo therapies was published on July 8, 2026. The article, titled "A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023," appeared in the journal Cureus. Afamelanotide is referenced within this review of vitiligo therapy trial literature. The publication covers a ten year span of randomized controlled trial research related to vitiligo treatments. No specific findings, outcomes, or conclusions from the review have been provided beyond its title and publication details. This entry reflects only the existence and bibliographic details of the publication as listed. Readers interested in the broader context of afamelanotide, including its approved regulatory status, can consult the compound overview for additional background information.
Afamelanotide Featured in Cureus Review of Vitiligo Trial Literature
See the full afamelanotide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42569625/